Lunai Bioworks Inc. (LNAI)
LNAI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.03
-7.21% on the day
Market cap
$4.7M
Nano cap
Revenue · 2026
$52K
No prior year to compare
Net income · 2026
-$3.6M
-6852.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:Revenues), period ending 2026-06-30, https://www.sec.gov/Archives/edgar/data/1527728/000173112226001339/0001731122-26-001339-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2026-06-30.
Profile
| Field | Value |
|---|---|
| Ticker | LNAI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001527728 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2026
| Line | Value |
|---|---|
| Revenue | $52K |
| Net income | -$3.6M |
| Operating income | Not in SEC XBRL data |
| Net margin | -6852.0% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 89.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B5 | 424B5 | 2025-12-03 |
| Latest annual report FORM 10-K | 10-K | 2026-10-13 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-05-15 |
| Latest current report FORM 8-K | 8-K | 2026-10-09 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 592 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| XTLB | XTL Biopharmaceuticals Ltd. | $1.98 | +3.12% | $4.9M |
| XBIO | Xenetic Biosciences Inc. | $2.10 | -0.94% | $4.9M |
| JUNS | Jupiter Neurosciences Inc. | $3.36 | +10.53% | $4.4M |
| ENLV | Enlivex Ltd. | $0.2224 | -12.10% | $4.4M |
| PCSA | Processa Pharmaceuticals Inc. | $1.77 | -6.84% | $5.0M |
| NCNA | NuCana plc American Depositary Share | $1.05 | -2.78% | $4.4M |
| KALA | KALA BIO Inc. | $0.2600 | -7.14% | $5.0M |
| AZTR | Azitra Inc | $0.0715 | -39.20% | $4.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier